Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine Brückner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|March 10, 2022
Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug CombinationsMarkus Wild, Friedrich Hahn, Nadine Brückner, et al.
International Journal of Molecular Sciences|December 10, 2021
Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus ActivityFriedrich Hahn, Stuart T Hamilton, Christina Wangen, et al.
Plos Pathogens|February 10, 2025
Repression of varicella zoster virus gene expression during quiescent infection in the absence of detectable histone depositionJiayi Wang, Nadine Brückner, Simon Weissmann, et al.
Pharmaceutics|February 24, 2024
An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus ReactivityDongHoon Yu, Sabrina Wagner, Martin Schütz, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|March 10, 2022
Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug CombinationsMarkus Wild, Friedrich Hahn, Nadine Brückner, et al.
International Journal of Molecular Sciences|December 10, 2021
Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus ActivityFriedrich Hahn, Stuart T Hamilton, Christina Wangen, et al.
Plos Pathogens|February 10, 2025
Repression of varicella zoster virus gene expression during quiescent infection in the absence of detectable histone depositionJiayi Wang, Nadine Brückner, Simon Weissmann, et al.
Pharmaceutics|February 24, 2024
An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus ReactivityDongHoon Yu, Sabrina Wagner, Martin Schütz, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 1